Clinical Trial Update: Long-Term Efficacy and Safety of CT-P10 in Patients With RA [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports long-term efficacy and safety data for CT-P10 in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CT-P10 (rituximab biosimilar)

Snippet

Sponsor: Celltrion | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED